Evaluation of penicillin-based inhibitors of the class A and B β-lactamases from Bacillus anthracis

Biochemical and Biophysical Research Communications

Volumn 313, Issue 3, 2004, Pages 541-545

  Beharry, Zanna ^a   Chen, Hansong ^b   Gadhachanda, Venkat R ^b   Buynak, John D ^b   Palzkill, Timothy ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SOUTHERN METHODIST UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CATECHOL DERIVATIVE; CLAVULANIC ACID; IRON CHELATE; PENICILLIN DERIVATIVE; PIPERACILLIN; PYRIDINE DERIVATIVE; TAZOBACTAM; THIOL DERIVATIVE; ZINC DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS ANTHRACIS; DRUG BINDING; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION;

BACILLUS ANTHRACIS; ESCHERICHIA COLI;

EID: 0347694723     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.158     Document Type: Article

References (27)

1. Navas E. Problems associated with potential massive use of antimicrobial agents as prophylaxis or therapy of a bioterrorist attack. Clin. Microbiol. Infect. 8:2002;534-539.
2. Cavallo J.D., Ramisse F., Girardet M., Vaissaire J., Mock M., Hernandez E. Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000. Antimicrob. Agents Chemother. 46:2002;2307-2309.
3. Brook I., Eliott T.B., Pryor H.I., Sautter T.E., Gnade B.T., Thakar J.H., Knudson G.B. In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones. Int. J. Antimicrob. Agents. 18:2001;559-562.
4. Petrosino J., Cantu C., Palzkill T. beta-Lactamases: protein evolution in real time. Trends Microbiol. 6:1998;323-327.
5. Majiduddin F.K., Materon I.C., Palzkill T. Molecular analysis of beta-lactamase structure and function. Int. J. Med. Microbiol. 292:2002;1-11.
6. Chen Y., Succi J., Tenover F.C., Koehler T.M. Beta-lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain. J. Bacteriol. 185:2003;823.
7. Materon I.C., Queenan A., Koehler T., Bush K., Palzkill T. Biochemical characterization of beta-lactamase enzymes Bla1 and Bla2 from Bacillus anthracis. Antimicrob. Agents Chemother. 47:2003;2040-2042.
8. Lee N., Yuen K.Y., Kumana C.R. Clinical role of beta-lactam/beta- lactamase inhibitor combinations. Drugs. 63:2003;1511-1524.
9. Payne D.J., Du W., Bateson J.H. Beta-lactamase epidemiology and the utility of established and novel beta-lactamase inhibitors. Expert Opin. Investig. Drugs. 9:2000;247-261.
10. J.D. Buynak, H. Chen, L. Vogeti, V.R. Gadhachanda, R. Shaw, Unique beta-lactamase inhibitors that target both metallo- and serine-beta-lactamases, in: Abstracts of Papers, 224th ACS National Meeting, Boston, MA, USA, August 18-22, 2002, MEDI-048.
11. ′ beta-substituted penam sulfones as beta-lactamase inhibitors Bioorg. Med. Chem. Lett. 9:1999;1997-2002.
12. Lemozy J., Sirot D., Chanal C., Huc C., Labia R., Dabernat H., Sirot J. First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains. Antimicrob. Agents Chemother. 39:1995;2580-2582.
13. Heinisch L., Wittmann S., Stoiber T., Berg A., Ankel-Fuchs D., Mollmann U. Highly antibacterial active aminoacyl penicillin conjugates with acylated bis-catecholate siderophores based on secondary diamino acids and related compounds. J. Med. Chem. 45:2002;3032-3040.
14. Garner B.L., Arceneaux J.E.L., Byers B.R. Siderophore production and iron acquisition in Bacillus anthracis. American Society for Microbiology Conference Abstracts. 2001;124.
15. Bonomo R.A., Rice L.B. Inhibitor resistant class A beta-lactamases. Front. Biosci. 4:1999;34-41.
16. Therrien C., Levesque R.C. Molecular basis of antibiotic resistance and beta-lactamase inhibition by mechanism-based inactivators: perspectives and future directions. FEMS Microbiol. Rev. 24:2000;251-262.
17. Prosperi-Meys C., Llabres G., de Seny D., Soto R.P., Valladares M.H., Laraki N., Frere J.M., Galleni M. Interaction between class B beta-lactamases and suicide substrates of active-site serine beta-lactamases. FEMBS Lett. 443:1999;109-111.
18. Garcia-Saez I., Hopkins J., Papamicael C., Franceschini N., Amicosante G., Rossolini G.M., Galleni M., Frere J.M., Dideberg O. The 1.5 Angstrom structure of Chryseobacterium meningosepticum zinc beta-lactamase in complex with the inhibitor, D-captopril. J. Biol. Chem. 278:2003;23868-23873.
19. Concha N.O., Janson C.A., Rowling P., Pearson S., Cheever C.A., Clarke B.P., Lewis C., Galleni M., Frère J.M., Payne D.J., Bateson J.H., Abdel-Meguid S.S. Crystal structure of the IMP-1 metallo-beta lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor. Biochemistry. 39:2000;4288-4298.
20. Buynak J.D., Wu K., Bachmann B., Khaanis D., Hua L., Nguyen H.K., Carver C.L. Synthesis and biological activity of 7-alkylidenecephems. J. Med. Chem. 38:1995;1022-1034.
21. Song H.K., Oh J.I., Kim M.Y., Kim Y.Z., Kim I.C., Kwak J.H. In-vitro and in-vivo antibacterial activity of LB10517, a novel catechol-substituted cephalosporin with a broad antibacterial spectrum. J. Antimicrob. Chemother. 37:1996;711-726.
22. ′ catechol-containing residues J. Med. Chem. 35:1992;2631-2642.
23. Yang Y., Rasmussen B.A., Shlaes D.M. Class A beta lactamases: enzyme inhibitor interactions and resistance. Pharmacol. Ther. 83:1999;141-151.
24. Brown J.S., Holden D.W. Iron acquisition by Gram-positive bacterial pathogens. Microbes Infect. 4:2002;1149-1156.
25. Brochu A., Brochu N., Nicas T.I., Parr T.R., Minnick A.A., Dolence E.K., McKee J.A., Miller M.J., Lavoie M.C., Malouin F. Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria. Antimicrob. Agents Chemother. 36:1992;2166-2175.
26. Lalitha M., Thomas M. Penicillin resistance in Bacillus anthracis. Lancet. 349:1997;1522.
27. Bradaric N., Punda-Polic V. Cutaneous anthrax due to penicillin- resistant Bacillus anthracis transmitted by an insect bite. Lancet. 340:1992;306-307.